Such neuro-immunomodulatory changes would manifest as increased expression of NGF, trkA, NK1 receptors, and substance P, particularly in children with OSA. Such changes in turn could facilitate AT ...

It belongs to a class of drugs called neurokinin-1 (NK1) receptor antagonists. As a potent antiemetic, the medication works ...